Trial intelligence / Profile preview

Intravenous lidocaine and postoperative sleep in laparoscopic colorectal cancer surgery

ChiCTR2000038184Phase 4Recruiting

Sponsor
General Hospital of Ningxia Medical University
Start
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of lidocaine in colorectal cancer (CRC) and sleep disorder (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoint: Postoperative sleep function. Started Oct 2020; status: recruiting.

02

Drugs

lidocaine
03

Conditions

colorectal cancer (CRC)sleep disorder

Beyond the preview

Go deeper on ChiCTR2000038184.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000038184.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call